New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Hearing loss linked to early memory and thinking problems

Hearing loss linked to early memory and thinking problems

by Alzheimer's Research UKResearchers at the Alzheimer's Association International Conference 2017 have suggested that people with a family history of Alzheimer's disease who experien
Neurology March 07,2024
Hearing loss linked to early memory and thinking problems

Hearing loss linked to early memory and thinking problems

by Alzheimer's Research UKResearchers at the Alzheimer's Association International Conference 2017 have suggested that people with a family history of Alzheimer's disease who experien
Neurology March 07,2024
Curry spice holds clues to Alzheimer's drug targets

Curry spice holds clues to Alzheimer's drug targets

by Alzheimer's Research UKCalifornian researchers have shed more light on the action of an experimental Alzheimer's drug based on a modified component of the curry spice turmeric. The res
Neurology March 07,2024
Curry spice holds clues to Alzheimer's drug targets

Curry spice holds clues to Alzheimer's drug targets

by Alzheimer's Research UKCalifornian researchers have shed more light on the action of an experimental Alzheimer's drug based on a modified component of the curry spice turmeric. The res
Neurology March 07,2024
Potential Alzheimer's medication shows promise in mouse model of neurodegenerative disease

Potential Alzheimer's medication shows promise in mouse model of neurodegenerative disease

by JCI JournalsMemory loss and other cognitive symptoms of Alzheimer's disease are attributed, in part, to the degeneration of acetylcholine-producing neurons. Acetylcholinesterase inhibitors are
Neurology March 07,2024
Potential Alzheimer's medication shows promise in mouse model of neurodegenerative disease

Potential Alzheimer's medication shows promise in mouse model of neurodegenerative disease

by JCI JournalsMemory loss and other cognitive symptoms of Alzheimer's disease are attributed, in part, to the degeneration of acetylcholine-producing neurons. Acetylcholinesterase inhibitors are
Neurology March 07,2024
Alzheimer's gene associated with failure to adapt to cognitive challenge in healthy adults

Alzheimer's gene associated with failure to adapt to cognitive challenge in healthy adults

by Society for NeuroscienceHealthy adults carrying the gene APOE4—the strongest known genetic risk factor for Alzheimer's disease (AD)—may struggle to adapt their brain activity to increasing
Neurology March 07,2024
Alzheimer's gene associated with failure to adapt to cognitive challenge in healthy adults

Alzheimer's gene associated with failure to adapt to cognitive challenge in healthy adults

by Society for NeuroscienceHealthy adults carrying the gene APOE4—the strongest known genetic risk factor for Alzheimer's disease (AD)—may struggle to adapt their brain activity to increasing
Neurology March 07,2024
Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

by Boston University Medical CenterAs the number of patients with Alzheimer's disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed
Neurology March 07,2024
Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

by Boston University Medical CenterAs the number of patients with Alzheimer's disease (AD) rapidly increases, new treatments as well as blood tests that are simple and can be easily performed
Neurology March 07,2024
Vitamin C deficiency and mitochondrial dysfunction in Alzheimer's disease

Vitamin C deficiency and mitochondrial dysfunction in Alzheimer's disease

by Gabrielle Rushing,Vanderbilt UniversityEarly clinical features of sporadic Alzheimer's disease include alterations in mitochondrial functionthat appearprior to classical featu
Neurology March 07,2024
Vitamin C deficiency and mitochondrial dysfunction in Alzheimer's disease

Vitamin C deficiency and mitochondrial dysfunction in Alzheimer's disease

by Gabrielle Rushing,Vanderbilt UniversityEarly clinical features of sporadic Alzheimer's disease include alterations in mitochondrial functionthat appearprior to classical featu
Neurology March 07,2024
Emergency but not elective hospital admissions linked to faster memory and thinking decline

Emergency but not elective hospital admissions linked to faster memory and thinking decline

by Alzheimer's Research UKResearchers in Chicago have investigated the link between hospital admissions and memory and thinking problems. Existing research indicates that older people are at
Neurology March 07,2024
Emergency but not elective hospital admissions linked to faster memory and thinking decline

Emergency but not elective hospital admissions linked to faster memory and thinking decline

by Alzheimer's Research UKResearchers in Chicago have investigated the link between hospital admissions and memory and thinking problems. Existing research indicates that older people are at
Neurology March 07,2024
Professional classical musicians are not protected from dementia

Professional classical musicians are not protected from dementia

by University of HelsinkiListening and practicing music have been reported to have many beneficial effects on human health. The effect of music on human brain has been previously studied in young
Neurology March 07,2024
Professional classical musicians are not protected from dementia

Professional classical musicians are not protected from dementia

by University of HelsinkiListening and practicing music have been reported to have many beneficial effects on human health. The effect of music on human brain has been previously studied in young
Neurology March 07,2024
More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

by University of Eastern FinlandPsychotropic drug use is rather common among persons aged 90 years or more diagnosed with Alzheimer's disease, compared with those who were diagnosed at younge
Neurology March 07,2024
More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

by University of Eastern FinlandPsychotropic drug use is rather common among persons aged 90 years or more diagnosed with Alzheimer's disease, compared with those who were diagnosed at younge
Neurology March 07,2024
Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

by Bentham Science PublishersNicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due
Neurology March 07,2024
Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

by Bentham Science PublishersNicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due
Neurology March 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com